To early predict pCR in HER2-positive breast cancer patients using a Siamese multi-task network (SMTN) which performs tumor segmentation of pre- and early-treatment longitudinal ultrasound images, followed by capturing the dynamic change information of the tumor. This evidence concerns the gene ERBB2 and breast carcinoma.